Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status now shows that enrollment is closed, and new guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added. Minor header formatting changes and a version update to v3.6.0 (replacing v3.5.5) are also included.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page now displays Revision: v3.5.5 in place of Revision: v3.5.4, indicating an update to the site revision rather than content changes.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a small update to the entry version.SummaryDifference0.0%

- Check59 days agoChange DetectedThe footer revision label was updated from v3.5.2 to v3.5.3, indicating a site software/content build change without affecting the clinical trial information shown on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedA new revision tag v3.5.2 was added and the previous tag v3.5.0 was removed.SummaryDifference0.0%

- Check94 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; no observable changes to the page content.SummaryDifference0.0%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.